本頁面由Tiger Trade Technology Pte. Ltd.提供服務

思科

109.74
-0.3300-0.30%
成交量:516.78萬
成交額:5.71億
市值:4,335.93億
市盈率:32.95
高:110.99
開:110.66
低:109.37
收:110.07
52周最高:130.37
52周最低:66.38
股本:39.51億
流通股本:39.41億
量比:0.49
換手率:0.13%
股息:1.66
股息率:1.51%
每股收益(TTM):3.33
每股收益(LYR):3.33
淨資產收益率:27.32%
總資產收益率:7.98%
市淨率:8.62
市盈率(LYR):32.95

資料載入中...

2021/07/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/06/29

重要事件披露

8-K - Current report
2021/05/25

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/19

重要事件披露

8-K - Current report
2021/05/14

重要事件披露

8-K - Current report
2021/04/02

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/08

重要事件披露

8-K - Current report
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

重要事件披露

8-K - Current report
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/25

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/01/25

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/01/25

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/01/25

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/01/25

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/01/25

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/01/25

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/01/25

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments